以往VT基质射频导管切除手术对患者电风暴的影响
Cosmin Cojocaru1,2, Alexandrina Năstasă3, Mihnea Hîrceagă1
1Faculty of Medicine, Department of Cardiothoracic Pathology, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Kardiologia polska
|March 20, 2025
概括
在电风暴患者中,重复导管切除对于心室性心力衰竭显示出与单次切除相似的结果. 这表明,尽管复杂性增加,重复手术仍然是一个可行的选择.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗器械技术 医疗器械技术
背景情况:
- 切除后的风性心跳动 (VT) 可能不耐治疗,增加死亡率.
- 重复射频切除 (RFA) 是有利于减少静脉瘤负担,但电风暴患者的数据有限.
研究的目的:
- 在电风患者中比较单次和重复RFA之间的患者和程序特征.
- 评估单次与重复RFA队列中的长期全因死亡率和复发率.
主要方法:
- 对101名连续接受RFA的电风暴患者的回顾性分析.
- 通过编程心室刺激来评估静脉动诱导性.
- 患者/手术因素,全因死亡率和消去后第一年内复发的比较.
主要成果:
- 重复RFA患者更频繁地患有非缺血性心肌病并需要心上膜切除.
- 在重复RFA组 (14.8%对1.6%) 中,心上接入并发症的发生率更高.
- 在随访期间和消去后的第一年,单次和重复RFA组之间的所有原因死亡率和VT复发是可比的.
结论:
- 在电风暴患者中,重复RFA与与单次RFA相比,与相似的死亡率和复发率有关.
- 尽管在重复的RFA病例中复杂性增加和基质负担增加,但结果仍然可比.
相关概念视频
Electroconvulsive Therapy
21
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
872
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
872


